search:concurrent chemoradiotherapy相關網頁資料

瀏覽:849
日期:2024-05-07
1. Asian Pac J Cancer Prev. 2014;15(20):8987-92. Definitive concurrent chemoradiotherapy in cervical cancer - a university of malaya medical centre experience. Zamaniah WW, Mastura M, Phua C, Adlinda A, Marniza S, Rozita A. BACKGROUND: The efficacy of ......
瀏覽:801
日期:2024-05-10
This study aimed to evaluate acute major toxicities, the response rate, 3-year overall survival and progression-free survival rate of locally advanced nasopharyngeal carcinoma patients on concurrent carboplatin chemoradiotherapy followed by carboplatin an...
瀏覽:1424
日期:2024-05-10
Combined radiotherapy and chemotherapy is considered the standard of care for locally advanced nasopharyngeal carcinoma (LA-NPC) in Epstein-Barr virus infection endemic area. This study compared the long-term outcomes between LA-NPC patients treated with ...
瀏覽:475
日期:2024-05-08
Abstract Purpose: To test the concept of taxane sequencing in combined-modality therapy, this phase II trial (S9504) evaluated consolidation docetaxel after concurrent chemoradiotherapy in patients with pathologically documented stage IIIB non–small ......
瀏覽:844
日期:2024-05-12
The optimal sequencing of chemotherapy and radiotherapy after breast surgery was largely studied but remains controversial. Concurrent chemo-radiotherapy is a valuable method for adjuvant treatment of breast cancer which is under ongoing research program ...
瀏覽:1317
日期:2024-05-09
therapy as in the intergroup 0099 trial.[16] The 3-year overall survival was improved with the addition of chemotherapy (80 vs 65%; p= 0.0061). As in the intergroup trial, grade 3-4 toxicity was more common in the chemoradiotherapy group. Distant failure ...
瀏覽:1073
日期:2024-05-09
This is a randomized, multicenter, phase III trial comparing induction chemotherapy with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) followed by concurrent chemoradiotherapy (Arm A) to concurrent chemoradiotherapy alone (Arm B), in nasopharyngeal cancer...
瀏覽:1067
日期:2024-05-11
Table 1. Phase III Trials of Definitive Radiotherapy Versus Concurrent Chemoradiotherapy for Advanced Head and Neck Cancer. Trial Patients (n) Local control Toxicity (grade 3- 4) Distant metastases Overall survival Ref. Intergroup 0099 147 NPC Crude RT 74...